期刊文献+

DRD2基因多态性与美沙酮维持治疗剂量的关联性研究

Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program
原文传递
导出
摘要 目的探讨DRD2基因的3个单核苷酸多态性位点(rs1800497、rs6275以及rs1799978)与美沙酮维持治疗剂量之间的关联。方法采用病例对照研究的方法,使用Quanto软件估算样本量至少180人。实际共纳入美沙酮维持治疗者257人,其中低剂量对照组89人,高剂量病例组168人。收集研究对象的一般情况、既往吸毒状况以及服药状况等信息,并对其进行DRD2基因分型,以探讨DRD2基因的多态性与美沙酮维持治疗剂量的关联性。结果DRD2基因rs6275位点基因型在不同美沙酮维持治疗剂量组间的分布差异有统计学意义,TC基因携带者相比于TT基因携带者(OR=0.338,95%CI:0.115~0.986),TC+CC基因型携带者相比于TT基因型携带者(OR=0.352,95%CI:0.127—0.975)可能需要更低的美沙酮维持治疗剂量。尚未发现rs6275位点的等位基因,rs1800497位点、rs1799978位点的等位基因以及各遗传模型下的基因型在不同美沙酮治疗剂量组间分布的差异有统计学意义。结论DRD2基因rs6275位点与美沙酮维持治疗剂量有关联。尚未发现rs1800497位点、rs1799978位点与美沙酮维持治疗剂量有关联。 Objective To investigate the association between three single nucleotide polymorphism (SNP) genes DRD2 (rs1800497, rs6275, and rs1799978) and the dosage used on methadone maintenance treatment (MMT). Methods From the methadone maintenance treatment centers, 257 MMT patients were recruited to participate in a case-control study and divided into two groups--control groups under low dosage (n= 89) and case (n= 168) group with high dosage. Quanto software was used to estimate the sample size as 180. Information related to social- demographic status, history on drug use and medication were collected. And DRD2 SNPs were genotyped to explore the relationship between polymorphism of DRD2 gene and the dosage of methadone maintenance treatment. Results Distributions of DRD2 rs6275 between different groups were significantly different. Patients carrying TC genotype needed lower dose of methadone when compared to the patients that carrying CC genotype counterparts (0R=0.338, 95% CI: 0.115-0.986). Patients that carrying C allele at rs6275 needed lower methadone dose than those that carrying genotype TT (OR= 0.352, 95% CI: 0.127-0.975). Distributions of genotypes, alles in the other two SNPs (rs1800497, rs1799978) were not significantly different between groups under different dosages. Conclusion DRD2 rs6275 was associated with dosage of methadone used for the MMT patients. However, no significant associations were found between rs 1800497, rs 1799978 and the dosage of methadone.
作者 段鹭茜 李杏莉 胡佩武 罗芮 罗希 陈颖怡 Duan Luxi;Li Xingli;Hu peiwu;Luo Rui;Luo Xi;Chen Yingyi(Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410078, China;Department of Scientific Research, Xiangya Hospital, Central South University, Changsha 410008, Chin)
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2018年第2期194-198,共5页 Chinese Journal of Epidemiology
基金 国家自然科学基金(81202257) 中南大学教师研究基金(2013JSJJ032) 教育部留学回国人员科研启动基金
关键词 美沙酮维持治疗 DRD2基因 单核苷酸多态性 治疗剂量 Methadone maintenance treatment DRD2 gene Single nucleotide polymorphism Treatment dose
  • 相关文献

参考文献2

二级参考文献19

  • 1Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction[J]. JAMA, 1998,280(22): 1936-1943. DOI: 10.1001/ jama.280.22.1936.
  • 2Kuehn BM. Methadone treatment marks 40 years [J]. JAMA, 2005,294(8) :887-889. DOI: lO.lO01/jama.294.8.887.
  • 3Wang L. Overview of the HIV/AIDS epidemic, scientific research and government responses in China [ J ]. AIDS, 2007,21 Suppl 8 : $3 -7. DOI : 10.1097/01 .aids.0000304690.24390.c2.
  • 4Sullivan SG, Wu Z, Detels R. Time to first treatment interruption in the Chinese methadone maintenance treatment programme [ J ]. Drug Alcohol Depend, 2013, 133 (2) : 427-432. DOI: 10.1016/j.drugalcdep .2013.06.021.
  • 5Wang SC, Ho IK, Tsou HH, et al. Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort [J]. OMICS, 2013, 17 (10) :519-526. DOI: 10.1089/omi.2012.0068.
  • 6Levran O, Peles E, Hamon S, et al. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addicfion[J]. Addict Biol,2013, 18(4) : 709-716. DOI: 10.1111/ j. 1369-1600.2011.00349.x.
  • 7Tian JN, Ho IK, Tsou HH, et al. UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients [J]. Pharmacogenomics, 2012, 13 (8) : 879-888. DOI: 10.2217/pgs.12.69.
  • 8Clark CB, Hendricks PS, Lane PS, et al. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision[J]. Addict Behav, 2014,39(12) : 1736-1740. DOI: 10.1016/j.addbeh.2014.07.011.
  • 9Audet M, Bouvier M. Restructuring G-protein-coupled receptor activation [J]. Cell, 2012, 151 (1) : 14-23 DOI: 10.1016/j. cei1.2012.09.003.
  • 10Zuo Z. The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance [J]. Anesth Analg, 2005, 101 (3) : 728-734. DOI: 10.1213/01 .ANE.0000160588.32007.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部